MEETING VENUE
Marmara Taksim Hotel. Istanbul, Turkey
DATE
27th – 28th June 2019
SPEAKERS
8 Speakers
SEATS
200
Organized by:
Scientific Secretariat:
Technical Secretariat:
Endorsed by
Other sponsors
Marmara Taksim Hotel. Istanbul, Turkey
27th – 28th June 2019
8 Speakers
200
Doctor Emmanouil Papadakis is Head of Hemostasis Dept. at Papageorgiou hospital of Thessaloniki and Senior Consultant at Hematology Department-Hemostasis Unit of Papageorgiou hospital of Thessaloniki.
He finished his Medical Degree at Aristoteles University of Thessaloniki in 1994. In 2003, he achieved the Medical Specialty of Hematology at Hematology Department of G. Papanikolaou Hospital Thessaloniki. In 2011, he obtained the Master of Science regarding Hemostasis and Blood Banking in Kapodistrian University of Athens.
Doctor Papadakis is National Coordinator of Greece for the Riete Registry, Board Member of the Hemostasis Subcommitee of Greek Society of Hematology and of the North Greek Subcommitee of Greek Society of Hematology. He is also member of many Greek Society, as the International Society of Thrombosis and Hemostasis, the Mediterranean League against Thromboembolic Disease.
During the past 10 years, he has published many researches and has participated in many lectures in both national and international conferences, mainly focusing in the topics of venous thromboembolism along with gynecologic & obstetric complications.
Dresden University Clinic, Germany
Jan Beyer-Westendorf, born in Dresden in 1971, received his medical training at the University Hospitals Carl-Gustav Carus Dresden, at the Charité in Berlin and at Lincoln County Hospital Lincolnshire, UK.
After his training, he completed his residency in Internal Medicine in Dresden, and specialised in the fields of Intensive Care Medicine (2006), Vascular Medicine (2007) and Haemostaseology (2009). From 2007 to 2015 he was the Deputy Head of Division Angiology and in 2009 he became Head of the Thrombosis Research Unit at the University Hospitals Carl-Gustav Carus Dresden, Department of Medicine 1; Division Hematology. Professor.Beyer-Westendorfs main research interests are venous thromboembolism, efficacy and safety of anticoagulant therapy, and risk factors, management and outcome of bleeding complications during antithrombotic therapy.
In 2012, he was appointed Assistant Professor for Internal Medicine and Vascular Medicine in the Medical Faculty of the Technical University Dresden, Germany. In 2016, Professor Beyer-Westendorf was appointed as Senior Lecturer Thrombosis & Hemostasis at King’s College, London, UK.
Jan Beyer-Westendorf has served in steering committees of numerous clinical trials in vascular medicine, including Phase III and Phase IV trials evaluating novel direct oral anticoagulants. Since 2011, Professor Westendorf manages a large regional prospective registry on the efficacy, safety and management aspects of oral anticoagulants in daily practice, which has currently over 3800 patients enrolled. He has authored and co-authored more than 150 well-received publications in peer-reviewed international journals as well as book chapters on different aspects of cardiovascular medicine. He serves as reviewer for various international journals, Blood, BMJ, Journal of Thrombosis and Haemostasis, The New England Journal of Medicine, Thrombosis and Haemostasis, Thrombosis Research among them.
Jan Beyer-Westendorf is married and proud father of three exhilarant kids.
He was born in İzmir in 1962. Graduated in 1985 at Ege University Faculty of Medicine.
Amasya Merzifon made compulsory service in the central health clinic. 16.3.1987 İstanbul University Cerrahpaşa Faculty of Medicine Department of thoracic and cardiovascular surgery expertise began my education. Specialty training in Scotland “Royal Infirmary of Edinburgh” Department of Cardiothoracic Surgery, he worked as a “Visiting fellow”. Completed my education specialization in 1993 and began working in the same Department as chief resident.
1994-1995 Castle Hill Hospital (UK) Center of Heart and Chest Surgery.
2003 Fellow of the European Board of Thoracic and Cardiovascular Surgeons (FEBCS)
2008-2012 National President of the Society of Vascular Surgery
2013-2014 President of the Asian Association of Vascular Surgery. Member of the Board of the European Society for Vascular Surgery and Secretary at the Asian Venous Forum.
2015-2017 President of the General Secretary of the Turkish Association for Cardiovascular Surgery.
At present he is Professor of Cardiovascular Surgery at the Istanbul University Cerrahpasa Medical Faculty.
He has published more than 60 articles in peer-reviewed international journals, published 55 books sections, participated within national and international meetings and congress related with his field.
Tankut Hakki AKAY, (F.A.C.S, Professor ,M.D)
Birth date: 10. March.1973
Primary school.: TED Ankara College
Secondary School TED Ankara College
High School: TED Ankara College
Medical School: Erciyes University Faculty of Medicine
Residency: Baskent University Faculty of Medicine, Department of Cardiovascular Surgery (1998-2003)
Instructor: Baskent University Faculty of Medicine, Department of Cardiovascular Surgery (2003- 2005)
Military Duty: Gülhane Military Medical Academy Department of Cardiovascular Surgery (2005-2006)
Instructor: Baskent University Faculty of Medicine, Department of Cardiovascular Surgery (2006- 2007)
Fellowship in Salzburg, Landesklinik Austria (2008)
Associate Professor M.D, Baskent University Faculty of Medicine, Department of Cardiovascular Surgery (since December 2008-2014)
Professor M.D, Baskent University Faculty of Medicine, Department of Cardiovascular Surgery (2014- present)
Memberships: European Society Of Vascular Surgery
Turkish Society of Vascular Surgery
Turkish Society of Phelobology
Turkish Society of Cardiovascular Surgery
American College of Surgeons
Turkish Society of Vascular and Endovascular SurgeryExecutive comitee member(2011-2014)
Turkish Society of Vascular and Endovascular Surgery Secretary General (2014-2018)
Turkish Society of Vascular and Endovascular Surgery President (2018- present)
European Society Of Vascular Surgery Trainee Executive Comitee Member (2008-2013)
European Society Of Vascular Surgery Turkish Councellor (2014-2017)
European Board Of Vascular Surgery Turkish Councellor (2017-present)
Fellow of American College of Surgeons ,F.A.C.S (2017)
Foreign Language: English
Marial status: Married and has a daughter
Alexander Cohen is a vascular physician and epidemiologist at Guy’s and St Thomas’ Hospital, King’s College, London, UK. Dr Cohen graduated with honours in Medicine and honours in Surgery from the University of Melbourne, Australia, and became a fellow of the Royal Australasian College of Physicians in 1990. He was awarded an MSc in epidemiology from the London School of Hygiene and Tropical Medicine, University of London, in 1991 with a thesis on the metabolic syndrome in South Asian populations. In 1998, he was awarded an MD with a thesis on the epidemiology of venous thromboembolism and thromboprophylaxis. He is a Fellow of the European Society of Cardiology.
In addition to his clinical work, Dr Cohen is involved in designing, managing and analysing clinical trials from Phase I to IV. He is the Chairman and a member of many international steering committees for multicentre trials, epidemiological and
pharmacoeconomic studies, and was previously the Director of Clinical Research and an epidemiologist in thrombosis research at King’s College Hospital.
Dr Cohen has written and co-authored over 450 publications and is on the editorial board of several journals. He has over 40 publications in The Lancet and New
England Journal of Medicine, as well as over 20 in British Medical Journal, Blood, Circulation, Annals of Internal Medicine and JAMA Internal Medicine.
Graduated from Athens Medical School in 1983 and completed his medical training in internal medicine in 1990. In 1995 awarded PhD from the University of London on the application of radiolabeled monoclonal antibodies in the treatment of Head and neck Cancer. He was appointed lecturer at St George’s Hospital Medical School 1996-1999, studying the application of allogeneic vaccines in Melanoma; then senior Lecturer and then Reader in cancer medicine at the University of Hull (1999-2010). He treats GI/GU cancers and melanoma.
He is currently Professor of Medical Oncology in the Hull York Medical School (HYMS) and consultant medical oncologist in the Hull University Teaching Hospitals (HUTH) NHS Trust. Clinical research interests include cancer associated thrombosis. He was the CI for the FRAGEM trial investigating the role of thromboprophylaxis in pancreatic cancer. His basic research interest is the trafficking of TF-microvesicles and their role in the cancer metastatic process.
Date and place of birth: 9 July 1974, Madrid, Spain
Medical degree: Universidad Autónoma, Madrid (1992-1998).
Degree Biostatistics in Health Sciences Universidad Autónoma, Barcelona (2010).
PhD, 2016, Universidad Complutense, Madrid: “A new genetic risk score for predicting venous thromboembolic events in cancer patients receiving chemotherapy”.
Medical Oncologist. Attending Physician. Medical Oncology Department. Hospital General Universitario Gregorio Marañón, Madrid, Spain
Head of the Cancer & Thrombosis Working Group of the Spanish Society of Medical Oncology (SEOM).
Assistant professor. Faculty of Medicine, Universidad Complutense, Madrid
Vice president Ethics Committee, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Author of more 140 abstracts and communications to national and international meetings (ASCO, ESMO, ISTH, ICTHIC Bérgamo, MASCC/ISO, SEOM, etc.)
Author of more than 30 papers in national and international Journals with impact factor
First author of the Cancer & Thrmbosis Guidelines of the Spanish Society of Medical Oncology (SEOM)
Date of birth: 31st March 1956
Social status: Married, three children
Present appointment: Professor of Medicine – staff member Department of
Medicine, section of Thrombosis and Hemostasis
Address: Leiden University Medical Center Room C7-68,
Albinusdreef 2, 2333ZA Leiden Netherlands
PO Box 9600, 2300 RC Leiden Netherlands
Telephone: 00 31 71 5262085 (staff secretariat)
E-mail: m.v.huisman@lumc.nl
Qualifications: MD PhD
Physician number: BIG-19021708601
GCP training: 24-5-2016
Date of issue: 26/02/2019
1975-1983: Training medical degree at the University of Amsterdam the Netherlands
1983-1988: PhD thesis; title: Diagnostic management of deep venous thrombosis
(promotores: Professor H.R. Buller and Professor J.W. ten Cate)
1988-1994: training Internal Medicine and Hematology Academic Medical Center
Amsterdam the Netherlands
1994- present: staff member department of Medicine, Tutor in Vascular Medicine
BROK Good Clinical Research Practice exam: 24 May 2016
Coordinator/primary investigator in several diagnostic and therapeutic studies in
arterial venous thromboembolism
1. Prometheus Study – Prospective study diagnosis of pulmonary embolism
2. Hestia Study – home treatment study in pulmonary embolism
3. Vesta Study – home treatment study in pulmonary embolism
4. Return Study: study to evaluate MR direct thrombus imaging in recurrent
DVT
5. Magnitude Study – study to evaluate MR direct thrombus imaging in clinically
suspected arm vein thrombosis
6. Nefros Study – randomised trial to prevent contrast induced nephropathy in
patients undergoing CT for pulmonary embolism detection
7. Salina Study – randomised trial to prevent contrast induced nephropathy in
patients undergoing CT with intravenous contrast dye
8. Helios Study randomised trial to prevent contrast induced nephropathy in
patients undergoing CT with intra-arterial contrast dye
2
9. Dabigatran in renal insufficiency – a pharmacological study of dabigatran in
patients with chronic kidney disease
10. Statin Intolerance Study – RCT of low dose statin in statin-intolerant patients
11. Pythia Study: study to evaluate baseline imaging in triage of arterial
complications in patients with idiopathic pulmonary embolism
Member Task Force European Guidelines ESC pulmonary embolism 2014 and 2019
Member ACCP guideline VTE 2016
Associate editor Thrombosis and Haemostasis
Regular reviewer for New Engl J Med, Lancet, J Thrombosis Haemost, Thrombosis
and Haemostasis, British J Hematol, Hematologica, Journal of Vascular Surgery,
Journal of Internal Medicine, European Respiratory J, European J Card, European
Journal of Internal Med
Member Regional Training Committee Internal Medicine (Leiden University Medical
Centre and affiliated hospitals)
Tutor in Vascular Medicine
Organisor National Thrombo-embolism congress, Course in Vascular Medicine
Member National Education Committee Vascular Medicine NIV
Chair National Consensus on Antithrombotic Treatment 2016
Member ACCP guidelines on VTE treatment
Member European Society of Cardiology guidelines on pulmonary embolism 2014
and 2019
Chair Gloria-AF registry – world wide registry of antithrombotic treatment in AF
G. PubMed publications – 359 as per 28 October 2018 (PUBMED index)
H. hobbies: family, golf, skiing, climbing hills and mountains, reading, good movies,
after dinner talking the night away
Juan Arcelus, MD, PhD, graduated in medicine from the University of Granada Medical School, Granada, Spain, in 1982, and obtained a PhD, specializing in thrombosis, from the same university in 1998. After completing his residency in general and gastrointestinal surgery at the University Hospital of Granada, Dr Arcelus served a research fellowship in the Department of Surgery at Northwestern University, Chicago, Illinois, USA, from 1989 to 1992. He was associate director of the Thrombosis and Hemostasis Group at Evanston Hospital, Evanston, Illinois, from 1990 to 1992.
Prof. Arcelus became professor of surgery at the University of Granada Medical School in 2003 and practices as an attending staff member in the Department of Surgery of the Hospital Universitario Virgen de las Nieves, also in Granada, and is Chairman of the Department of Surgery at the University of Granada Medical School since June 2016. His main research interests include the risk assessment, epidemiology, diagnosis, prevention, and follow-up of venous thromboembolism (VTE), particularly in surgical patients. He is also involved in research on the management of patients undergoing endocrine surgery.
He has been a member since 2001 in the International Computerized Registry of Patients with Venous Thromboembolism (RIETE), and coordinates the Working Group on Thrombosis of the Spanish Surgical Association. Prof. Arcelus has presented 230 abstracts and 226 lectures to national and international meetings, published more than 150 papers in peer-reviewed journals, and has written 30 book chapters. He is frequent reviewer for several journals, including Thrombosis and Haemostasis, Journal of Thrombosis and Haemostasis, Annals of Surgery, Chest, PLOS One, Thrombosis Research, Clinical Applied Thrombosis and Haemostasis, among others, and is member of the International Editorial Board of JAMA Surgery since 2013 to the present time.
Prof. Arcelus has been panellist in the 9th American College of Chest Physicians (ACCP) Guidelines for Antithrombotic and Thrombolytic Therapy and the 2013 and 2015 update of the American Society of Clinical Oncology (ASCO) guidelines on prevention and treatment of venous thromboembolism in cancer patients, and for the next 2019 edition of the ASCO guidelines on management of VTE. He has also participated in the recently published guidelines of the European Society of Anesthesiology (ESA) on VTE prevention, as well as in national guidelines in Spain for the prevention of VTE in ambulatory surgery and bariatric surgery.
Ingrid Bistervels (1989), MD, qualified as a medical doctor at the University of Amsterdam, the Netherlands, in 2015. She worked as a clinical doctor at the department of Internal Medicine at the Flevoziekenhuis in Almere year before she got involved in research.
Since April 2016 she is a PhD candidate supervised by Professor Saskia Middeldorp at the department of Vascular Medicine at the Academic Medical Center in Amsterdam. Her main fields of interest are pregnancy & thrombosis, women’s issues in the field thrombosis and long-term outcomes of VTE.
Dr Elvira Grandone, MD, is a Board certified Obstetrician and Gynaecologist with over 25 years of extensive experience in the field of molecular biology and genetics. Dr Grandone has conducted many clinical research trials serving as principal or local investigator. She has been involved in the compilation of guidelines and consensus conferences.
Dr. Grandone is Medical Director of the Hemostasis and Thrombosis Department, at the Institute “IRCCS Ospedale Casa Sollievo della Sofferenza”, at San Giovanni Rotondo, Foggia.
She is in the Executive Committee of the Italian Society of Thrombosis and Haemostasis and is member of the review board meeting in Mainz (Germany) for the “Integrated Research and Treatment Centers-IFB” (FUNDING BY THE GERMAN FEDERAL MINISTRY OF EDUCATION AND RESEARCH”).
Her research interests include: thrombophilia, venous thrombosis, pregnancy complications, genetic predisposition to multifactorial diseases, somatic mutations involved in the development of myeloproliferative neoplasms, genetic studies on rare bleeding disorders.
Recent Research Interests:
Research of new risk factors for pregnancy complications/venous thromboembolism and investigation of placentae from women with adverse obstetric outcomes (mainly studies of gene expression). Recent original data have been obtained in the field of annexin A5.
Many collaborations with national Centres of excellence for the diagnosis and treatment of thrombosis and haemorrhage are currently under way, as shown by many papers published.
He worked as consultant for urgent vascular surgery at the clinical doctor at the department of Internal Medicine at the Center of Disaster Medicine of Latvia for 5 years.
Since 2008 he works as vascular surgeon for out–patients at Pauls Stradins CUH and simultaneously from 2009 works also as vascular surgeon and phlebologist at Dr. Mauriņš Vein center located in Riga.
He has published several articles, presented oral and written communications at congressed related with his field.
Dr. Rits is member of the Latvian Society for vascular surgeons since 2003 and junior member of European Society for vascular surgery since 2004.
Professor Ingrid Pabinger is currently Professor of Haemostaseology at the Medical University Vienna, Vienna, Austria and Deputy Head of the Division of Hematology and Blood Coagulation and Head of the Coagulation Clinic at Vienna General Hospital.
Professor Pabinger’s clinical and scientific focus is in the field of coagulation disorders in both patients with hemophilia and idiopathic thrombocytopenic purpura, as well as those with thrombosis. Professor Pabinger has published over 390 peer-reviewed papers in the fields of thrombosis and haemostasis, hematology and internal medicine. She is a member of several international and national societies and is presently the Chair of the International Society on Thrombosis and Haemostasis (ISTH) Council.
She received her MD degree from the Medical School of National and Capodistrian University of Athens. She specialized in Haematology at University Hospital of Patras, where she acquired her PhD title. She has a long experience in haemostasis having an active role in the organization of the “Hematology and Anticoagulation Outpatient Clinic” in “KAT” General Hospital of Athens and ATTIKON University Hospital.
Since 2012 she is Head of Transfusion Service of “Saint Savvas” Oncology Hospital of Athens while she is responsible of the “Outpatient Clinic of Hemostasis Disorders”, in which patients with thrombotic and hemorrhagic disorders mainly with cancer, as well as pregnant women with thrombotic complications and abortions are monitored.
Professor Llau is anaesthesiologist and Head of Service of Anaesthesia and Post-Surgical Critical Care at Doctor Peset University Hospital in Valencia, Spain, and is Associated Professor of Human Physiology at the University of Valencia.
He received his medical degree in Valencia, Spain, in 1986, where he studied anaesthesiology at the Hospital La Fe, becoming an anaesthesiologist in 1993. His research interests are thrombosis and hemostasis, fluidtherapy and transfusion practice.
He is a member of several Spanish and International groups involved in the study of transfusion practice and hemostasis management. He is also a member of the board of examiners for the ESA European Diploma of Anaesthesiology.
Professor Llau has been the founder of the Transfusion and Haemostasis group of the Spanish Society of Anaesthesiology. He has published over 150 papers and book chapters related to transfusion practice and thrombosis and hemostasis, belonging to the Task Force of “Perioperative Bleeding Management” and “Perioperative Thromboprophylaxis” of the European Society of Anaesthesiology. He is the editor of five books on transfusion and haemostasis medicine.
Prof. Paolo Prandoni was born in 1947, and reached his graduation at the Faculty of Medicine of the University of Padua in 1971. He defended his PhD thesis at Amsterdam University in 1992. He became Associate Professor of Internal Medicine in 2000, and Full Professor of Internal Medicine in 2006.
His scientific interest has been mainly involved in studies addressing epidemiology, pathogenesis, diagnosis, prevention, treatment and follow-up of venous thromboembolism. His scientific activity is documented by almost 500 articles “in extenso” in high-impact scientific medical journals.
Training in Haematology at Fundación Jiménez Díaz, University Autónoma Madrid 1976-1980. Hematology Consultant at Ramón y Cajal Hospital in Madrid until 1993. Head of Hematology Department. Río Hortega University Hospital. Professor of Hematology in University of Valladolid.
Research formation in the Department of Haematology, Welsh National School of Medicine in Cardiff (1982), Blood Products Division, National Institute for Biological Standards and Control in London – United Kingdom (1985-1986). 182 articles published and 300 congress communications.